233 related articles for article (PubMed ID: 24746896)
1. Prevalence and impact of colony stimulating factor 3 receptor (CSF3R) mutations among Egyptian acute myeloid leukemia patients.
Aref S; El-Ghonemy M; Abouzeid T; El-Sabbagh A; El-Baiomy M
Leuk Res; 2014 Jun; 38(6):722-5. PubMed ID: 24746896
[TBL] [Abstract][Full Text] [Related]
2. A Truncated Granulocyte Colony-stimulating Factor Receptor (G-CSFR) Inhibits Apoptosis Induced by Neutrophil Elastase G185R Mutant: IMPLICATION FOR UNDERSTANDING CSF3R GENE MUTATIONS IN SEVERE CONGENITAL NEUTROPENIA.
Qiu Y; Zhang Y; Hu N; Dong F
J Biol Chem; 2017 Feb; 292(8):3496-3505. PubMed ID: 28073911
[TBL] [Abstract][Full Text] [Related]
3. Ultra-Sensitive
Klimiankou M; Uenalan M; Kandabarau S; Nustede R; Steiert I; Mellor-Heineke S; Zeidler C; Skokowa J; Welte K
Front Immunol; 2019; 10():116. PubMed ID: 30891028
[TBL] [Abstract][Full Text] [Related]
4. Role of CSF3R mutations in the pathomechanism of congenital neutropenia and secondary acute myeloid leukemia.
Klimiankou M; Mellor-Heineke S; Zeidler C; Welte K; Skokowa J
Ann N Y Acad Sci; 2016 Apr; 1370(1):119-25. PubMed ID: 27270496
[TBL] [Abstract][Full Text] [Related]
5. CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia.
Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Cao P; Ma X; Wang T; Zhang J; Zhang X; Lu P; Liu H
Cancer; 2018 Aug; 124(16):3329-3338. PubMed ID: 29932212
[TBL] [Abstract][Full Text] [Related]
6. Effect of the unfolded protein response and oxidative stress on mutagenesis in CSF3R: a model for evolution of severe congenital neutropenia to myelodysplastic syndrome/acute myeloid leukemia.
Sapra A; Jaksik R; Mehta H; Biesiadny S; Kimmel M; Corey SJ
Mutagenesis; 2020 Dec; 35(5):381-389. PubMed ID: 33511998
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.
Dong F; Brynes RK; Tidow N; Welte K; Löwenberg B; Touw IP
N Engl J Med; 1995 Aug; 333(8):487-93. PubMed ID: 7542747
[TBL] [Abstract][Full Text] [Related]
8. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia.
Beekman R; Valkhof MG; Sanders MA; van Strien PM; Haanstra JR; Broeders L; Geertsma-Kleinekoort WM; Veerman AJ; Valk PJ; Verhaak RG; Löwenberg B; Touw IP
Blood; 2012 May; 119(22):5071-7. PubMed ID: 22371884
[TBL] [Abstract][Full Text] [Related]
9. [Gene Mutation and Acute Leukemia Transformation of Severe Congenital Neutropenia- Review].
Chi ZH; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1580-1584. PubMed ID: 29070147
[TBL] [Abstract][Full Text] [Related]
10. Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis.
Skokowa J; Steinemann D; Katsman-Kuipers JE; Zeidler C; Klimenkova O; Klimiankou M; Unalan M; Kandabarau S; Makaryan V; Beekman R; Behrens K; Stocking C; Obenauer J; Schnittger S; Kohlmann A; Valkhof MG; Hoogenboezem R; Göhring G; Reinhardt D; Schlegelberger B; Stanulla M; Vandenberghe P; Donadieu J; Zwaan CM; Touw IP; van den Heuvel-Eibrink MM; Dale DC; Welte K
Blood; 2014 Apr; 123(14):2229-37. PubMed ID: 24523240
[TBL] [Abstract][Full Text] [Related]
11. Game of clones: the genomic evolution of severe congenital neutropenia.
Touw IP
Hematology Am Soc Hematol Educ Program; 2015; 2015():1-7. PubMed ID: 26637693
[TBL] [Abstract][Full Text] [Related]
12. Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia.
McLemore ML; Poursine-Laurent J; Link DC
J Clin Invest; 1998 Aug; 102(3):483-92. PubMed ID: 9691084
[TBL] [Abstract][Full Text] [Related]
13. Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia.
Link DC; Kunter G; Kasai Y; Zhao Y; Miner T; McLellan MD; Ries RE; Kapur D; Nagarajan R; Dale DC; Bolyard AA; Boxer LA; Welte K; Zeidler C; Donadieu J; Bellanné-Chantelot C; Vardiman JW; Caligiuri MA; Bloomfield CD; DiPersio JF; Tomasson MH; Graubert TA; Westervelt P; Watson M; Shannon W; Baty J; Mardis ER; Wilson RK; Ley TJ
Blood; 2007 Sep; 110(5):1648-55. PubMed ID: 17494858
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of a new auto-activating colony stimulating factor 3 receptor mutation (CSF3R-T595I) in acute myeloid leukemia and severe congenital neutropenia.
Beekman R; Valkhof M; van Strien P; Valk PJ; Touw IP
Haematologica; 2013 May; 98(5):e62-3. PubMed ID: 23508011
[No Abstract] [Full Text] [Related]
15. [Impact of
Li RQ; Wen XL; Zhang XL; Dong CX; Wang MF; Liu XX; Huang YJ; Tan YH; Chang JM; Zhang RJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):628-632. PubMed ID: 37356918
[TBL] [Abstract][Full Text] [Related]
16. CSF3R mutations were associated with an unfavorable prognosis in patients with acute myeloid leukemia with CEBPA double mutations.
Su L; Gao S; Tan Y; Lin H; Liu X; Liu S; Yang Y; Sun J; Li W
Ann Hematol; 2019 Jul; 98(7):1641-1646. PubMed ID: 31041512
[TBL] [Abstract][Full Text] [Related]
17. An acquired CSF3R mutation in an adult chronic idiopathic neutropenia patient who developed acute myeloid leukaemia.
Ikewaki J; Kawano R; Sato T; Imamura T; Kohno K; Ogata M; Ohtsuka E; Kadota J
Br J Haematol; 2012 Apr; 157(2):264-6. PubMed ID: 22146088
[No Abstract] [Full Text] [Related]
18. G-CSF receptor mutations in patients with congenital neutropenia.
Germeshausen M; Skokowa J; Ballmaier M; Zeidler C; Welte K
Curr Opin Hematol; 2008 Jul; 15(4):332-7. PubMed ID: 18536571
[TBL] [Abstract][Full Text] [Related]
19. Cooperating, congenital neutropenia-associated Csf3r and Runx1 mutations activate pro-inflammatory signaling and inhibit myeloid differentiation of mouse HSPCs.
Ritter M; Klimiankou M; Klimenkova O; Schambach A; Hoffmann D; Schmidt A; Kanz L; Link DC; Welte K; Skokowa J
Ann Hematol; 2020 Oct; 99(10):2329-2338. PubMed ID: 32821971
[TBL] [Abstract][Full Text] [Related]
20. High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.
Baer MR; Christiansen NP; Frankel SR; Brunetto VL; Mrózek K; Bloomfield CD; Herzig GP
Semin Oncol; 1993 Dec; 20(6 Suppl 8):6-12. PubMed ID: 7507264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
